Faeth Therapeutics FTH
NASDAQ FTH
$20.57 -0.22 (-1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

Faeth Therapeutics (FTH) Debt Ratio (2020 - 2021)

Updated

Faeth Therapeutics' (FTH) Debt Ratio stood at 0.00 in Q2 2021, up 4.0% from the prior quarter.

Analysis

Faeth Therapeutics (FTH) Debt Ratio (2020 - 2021) Analysis & Trends

For FY2020, Faeth Therapeutics' Debt Ratio came in at 0.03.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Faeth Therapeutics 115.80 Mn -319.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 0.00
Mar 31, 2021 0.00
Dec 31, 2020 0.03
API Access

Faeth Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=FTH&period=max&api_key=YOUR_API_KEY